Dr. Raymond Anton
Distinguished University Professor
Professor, Department of Psychiatry and Behavioral Sciences
Director, Center for Drug & Alcohol Programs
Director, Clinical Neurobiology Laboratory |
To read more about Dr. Anton, visit the Charleston Post & Courier High Profile feature about him by clicking here.
Education | Rutgers College, New Brunswick, NJ | B.A. | 1972 | Biosciences | | Rutgers School of Medicine, New Brunswick, NJ | M.D. | 1976 | Medicine | | Greenwich Hospital, Greenwich, CT | Internship | 1977 | Medicine | | Yale New Haven Hospital & Connecticut Mental Health Center, New Haven, CT | Residency | 1980 | Psychiatry | | Yale University School of Medicine, New Haven, CT | Postdoctoral | 1980 | Psychiatry |
Professional Experience | 1980-1985 | Assistant Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1980-1988 | Staff Psychiatrist, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC | | 1984-1988 | Director, Psychopharmacology Research, Veterans Affairs Medical Center, Charleston, SC | | 1985-1991 | Associate Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1988-present | Director, Clinical-Neurobiology Laboratories, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1991-present | Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC | | 1993-2001 | Director, Alcohol Medication Studies, Center for Drug and Alcohol Programs, MUSC, Charleston, SC | | 1995-present | Scientific Director for Clinical Research, Charleston Alcohol Research Center, MUSC, Charleston, SC | | 2001-present | Director, Center for Drug and Alcohol Programs, MUSC, Charleston, SC | | 2002-present | Distinguished University Professor, MUSC, Charleston, SC |
Awards and Honors
| 1991 | NIAAA Alcohol Psychosocial Research Review Committee (Member Clinical & Treatment Subcommittee; Chair, 1993-1994) | | 1992 | NIAAA Working Group on Methodology in Clinical Treatment Research Trials | | 1992 | NIAAA Task Force on Revision of the Treatment Assessment Manual | | 1996 | American College of Neuropsychopharmacology (elected member) | | 1997 | American Society of Addiction Medicine (diplomat) | | 1997 | Added Qualifications in Addiction Psychiatry | | 1999 | Board of Directors, Research Society on Alcoholism | | 1999-2002 | Board of Scientific Counselors of the National Institute of Alcohol Abuse and Alcoholism | | 2000-present | Member, Board of reviewing Editors, Alcoholism: Clinical and Experimental Research | | 2000-present | Chairman, Steering Committee, COMBINE Study | | 2001 | Treasurer, Research Society on Alcoholism | | 2003 | American College of Neuropsychopharmacology (elected fellow) | | 2005 | Vice-Chairman, Board of Trustees, Alcohol Beverage Medical Research Foundation | | 2007-2008 | President, Research Society on Alcoholism | | 2008 | Distinguished Fellow, American Psychiatric Association | | 2009 | Diplomate, American Board of Addiction Medicine |
Recent Publications
Anton RF, Litten RZ, Falk DE, Palumbo JM, Bartus RT, Robinson RL, Kranzler HR, Kosten TR, Meyer RE, O'Brien CP, Mann K & Meulien D. The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology 37(2):402-411, 2012. PMCID: 3242301
Bakhireva LN, Cano S, Rayburn WF, Savich RD, Leeman L, Anton RF & Savage DD. Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women. Alcohol & Alcoholism 47(6):683-687, 2012. PMCID: 3472616 Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, Oslin D, Purcell SM, Roberts AL, Smoller JW, Uddin M, Gelernter J & Koenen KC. No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Molecular Psychiatry 17(3):239-241, 2012. Chen J, Brunzell DH, Jackson K, van der Vaart A, Ma JZ, Payne TJ, Sherva R, Farrer LA, Gejman P, Levinson DF, Holmans P, Aggen SH, Damaj I, Kuo PH, Webb BT, Anton R, Kranzler HR, Gelernter J, Li MD, Kendler KS & Chen X. Correction: ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. PloS one 7(8) 2012. PMCID: 3435233 Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Farrer LA & Gelernter J. Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans. Biological Psychiatry 72(8):637-644, 2012. Ittiwut C, Yang BZ, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD, Covault J, Farrer LA & Gelernter J. GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcoholism: Clinical and Experimental Research 36(4):588-593, 2012. PMCID: 3250564 Li D, Zhao H, Kranzler HR, Oslin D, Anton RF, Farrer LA & Gelernter J. Association of COL25A1 with comorbid antisocial personality disorder and substance dependence. Biological Psychiatry 71(8):733-740, 2012. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D & Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: A critical review. Alcoholism: Clinical and Experimental Research 36(3):385-394, 2012. PMCID: 3249007 Xie P, Kranzler HR, Zhang H, Oslin D, Anton RF, Farrer LA & Gelernter J. Childhood adversity increases risk for nicotine dependence and interacts with alpha5 nicotinic acetylcholine receptor genotype specifically in males. Neuropsychopharmacology 37(3):669-676, 2012. PMCID: 3260970 Zhang H, Wang F, Kranzler HR, Anton RF & Gelernter J. Variation in regulator of G-Protein signaling 17 Gene (RGS17) is associated with multiple substance dependence diagnoses. Behavioral and Brain Functions 8(1):23, 2012. PMCID: 3406967
|
